Leishmania phagocytosis R-HSA-9664417
Parasite infection R-HSA-9664407
Immune System R-HSA-168256
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
FCGR3A-mediated phagocytosis R-HSA-9664422
FCGR3A-mediated IL10 synthesis R-HSA-9664323
FLT3 Signaling R-HSA-9607240
Regulation of signaling by CBL R-HSA-912631
Disease R-HSA-1643685
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Host Interactions of HIV factors R-HSA-162909
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by CSF3 (G-CSF) R-HSA-9674555
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Interleukins R-HSA-449147
FLT3 signaling through SRC family kinases R-HSA-9706374
Leishmania parasite growth and survival R-HSA-9664433
Innate Immune System R-HSA-168249
Nef and signal transduction R-HSA-164944
HIV Infection R-HSA-162906
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Leishmania infection R-HSA-9658195
FCGR activation R-HSA-2029481
Infectious disease R-HSA-5663205
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
HIV Infection R-HSA-162906
Signaling by CSF3 (G-CSF) R-HSA-9674555
Disease R-HSA-1643685
Immune System R-HSA-168256
Innate Immune System R-HSA-168249
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Cytokine Signaling in Immune system R-HSA-1280215
Infectious disease R-HSA-5663205
Leishmania phagocytosis R-HSA-9664417
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Leishmania infection R-HSA-9658195
FLT3 signaling through SRC family kinases R-HSA-9706374
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Parasite infection R-HSA-9664407
Regulation of signaling by CBL R-HSA-912631
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
FLT3 Signaling R-HSA-9607240
Signaling by Interleukins R-HSA-449147
FCGR3A-mediated phagocytosis R-HSA-9664422
Nef and signal transduction R-HSA-164944
Host Interactions of HIV factors R-HSA-162909
FCGR activation R-HSA-2029481
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Leishmania parasite growth and survival R-HSA-9664433
Signaling by Interleukins R-HSA-449147
Infectious disease R-HSA-5663205
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
FCGR3A-mediated phagocytosis R-HSA-9664422
Leishmania parasite growth and survival R-HSA-9664433
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Parasite infection R-HSA-9664407
Signaling by CSF3 (G-CSF) R-HSA-9674555
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Leishmania infection R-HSA-9658195
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Cytokine Signaling in Immune system R-HSA-1280215
Innate Immune System R-HSA-168249
FCGR activation R-HSA-2029481
Leishmania phagocytosis R-HSA-9664417
FLT3 Signaling R-HSA-9607240
Nef and signal transduction R-HSA-164944
FCGR3A-mediated IL10 synthesis R-HSA-9664323
HIV Infection R-HSA-162906
Host Interactions of HIV factors R-HSA-162909
Immune System R-HSA-168256
Regulation of signaling by CBL R-HSA-912631
FLT3 signaling through SRC family kinases R-HSA-9706374
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Disease R-HSA-1643685
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Leishmania parasite growth and survival R-HSA-9664433
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Leishmania phagocytosis R-HSA-9664417
FLT3 Signaling R-HSA-9607240
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Immune System R-HSA-168256
Innate Immune System R-HSA-168249
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
FCGR3A-mediated phagocytosis R-HSA-9664422
Nef and signal transduction R-HSA-164944
FCGR activation R-HSA-2029481
HIV Infection R-HSA-162906
Signaling by Interleukins R-HSA-449147
Host Interactions of HIV factors R-HSA-162909
FLT3 signaling through SRC family kinases R-HSA-9706374
Parasite infection R-HSA-9664407
Disease R-HSA-1643685
Cytokine Signaling in Immune system R-HSA-1280215
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Leishmania infection R-HSA-9658195
Infectious disease R-HSA-5663205
Regulation of signaling by CBL R-HSA-912631
Signaling by CSF3 (G-CSF) R-HSA-9674555
FCGR activation R-HSA-2029481
Leishmania infection R-HSA-9658195
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Innate Immune System R-HSA-168249
FLT3 signaling through SRC family kinases R-HSA-9706374
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Immune System R-HSA-168256
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Regulation of signaling by CBL R-HSA-912631
Host Interactions of HIV factors R-HSA-162909
Nef and signal transduction R-HSA-164944
Infectious disease R-HSA-5663205
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
HIV Infection R-HSA-162906
Leishmania phagocytosis R-HSA-9664417
FCGR3A-mediated phagocytosis R-HSA-9664422
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Parasite infection R-HSA-9664407
Cytokine Signaling in Immune system R-HSA-1280215
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Leishmania parasite growth and survival R-HSA-9664433
FLT3 Signaling R-HSA-9607240
Signaling by Interleukins R-HSA-449147
Signaling by CSF3 (G-CSF) R-HSA-9674555
Disease R-HSA-1643685
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
FCGR activation R-HSA-2029481
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Signaling by Interleukins R-HSA-449147
Disease R-HSA-1643685
FCGR3A-mediated phagocytosis R-HSA-9664422
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Leishmania phagocytosis R-HSA-9664417
Nef and signal transduction R-HSA-164944
Cytokine Signaling in Immune system R-HSA-1280215
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
FLT3 signaling through SRC family kinases R-HSA-9706374
HIV Infection R-HSA-162906
Host Interactions of HIV factors R-HSA-162909
Innate Immune System R-HSA-168249
Infectious disease R-HSA-5663205
FLT3 Signaling R-HSA-9607240
Leishmania infection R-HSA-9658195
Parasite infection R-HSA-9664407
Leishmania parasite growth and survival R-HSA-9664433
Regulation of signaling by CBL R-HSA-912631
Signaling by CSF3 (G-CSF) R-HSA-9674555
Immune System R-HSA-168256
FCGR activation R-HSA-2029481
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Infectious disease R-HSA-5663205
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Nef and signal transduction R-HSA-164944
Disease R-HSA-1643685
FCGR3A-mediated phagocytosis R-HSA-9664422
Leishmania parasite growth and survival R-HSA-9664433
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by Interleukins R-HSA-449147
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Innate Immune System R-HSA-168249
HIV Infection R-HSA-162906
FLT3 signaling through SRC family kinases R-HSA-9706374
Immune System R-HSA-168256
Leishmania infection R-HSA-9658195
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Parasite infection R-HSA-9664407
Signaling by CSF3 (G-CSF) R-HSA-9674555
FLT3 Signaling R-HSA-9607240
Host Interactions of HIV factors R-HSA-162909
Leishmania phagocytosis R-HSA-9664417
Regulation of signaling by CBL R-HSA-912631
Cytokine Signaling in Immune system R-HSA-1280215
Host Interactions of HIV factors R-HSA-162909
FLT3 signaling through SRC family kinases R-HSA-9706374
Infectious disease R-HSA-5663205
Signaling by Interleukins R-HSA-449147
Innate Immune System R-HSA-168249
Leishmania phagocytosis R-HSA-9664417
Signaling by CSF3 (G-CSF) R-HSA-9674555
Nef and signal transduction R-HSA-164944
Leishmania infection R-HSA-9658195
FLT3 Signaling R-HSA-9607240
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
HIV Infection R-HSA-162906
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
FCGR activation R-HSA-2029481
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
FCGR3A-mediated phagocytosis R-HSA-9664422
Regulation of signaling by CBL R-HSA-912631
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Cytokine Signaling in Immune system R-HSA-1280215
Immune System R-HSA-168256
Leishmania parasite growth and survival R-HSA-9664433
Disease R-HSA-1643685
Parasite infection R-HSA-9664407
Infectious disease R-HSA-5663205
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Leishmania phagocytosis R-HSA-9664417
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Signaling by Interleukins R-HSA-449147
Disease R-HSA-1643685
Leishmania parasite growth and survival R-HSA-9664433
Leishmania infection R-HSA-9658195
FCGR3A-mediated phagocytosis R-HSA-9664422
Regulation of signaling by CBL R-HSA-912631
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
FCGR activation R-HSA-2029481
Innate Immune System R-HSA-168249
HIV Infection R-HSA-162906
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Host Interactions of HIV factors R-HSA-162909
Immune System R-HSA-168256
Nef and signal transduction R-HSA-164944
Parasite infection R-HSA-9664407
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
FLT3 Signaling R-HSA-9607240
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
FLT3 signaling through SRC family kinases R-HSA-9706374
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by CSF3 (G-CSF) R-HSA-9674555
Innate Immune System R-HSA-168249
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Leishmania infection R-HSA-9658195
Cytokine Signaling in Immune system R-HSA-1280215
Regulation of signaling by CBL R-HSA-912631
Immune System R-HSA-168256
Signaling by CSF3 (G-CSF) R-HSA-9674555
FLT3 signaling through SRC family kinases R-HSA-9706374
Disease R-HSA-1643685
Leishmania phagocytosis R-HSA-9664417
HIV Infection R-HSA-162906
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Nef and signal transduction R-HSA-164944
Infectious disease R-HSA-5663205
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Parasite infection R-HSA-9664407
FCGR3A-mediated phagocytosis R-HSA-9664422
Host Interactions of HIV factors R-HSA-162909
Leishmania parasite growth and survival R-HSA-9664433
FLT3 Signaling R-HSA-9607240
Signaling by Interleukins R-HSA-449147
FCGR activation R-HSA-2029481
The role of Nef in HIV-1 replication and disease pathogenesis R-HSA-164952
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Inactivation of CSF3 (G-CSF) signaling R-HSA-9705462
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988

Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244
Non-integrin membrane-ECM interactions R-HSA-3000171
Extracellular matrix organization R-HSA-1474244

Signaling by VEGF R-HSA-194138
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by NOTCH R-HSA-157118
Signal Transduction R-HSA-162582
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signal Transduction R-HSA-162582
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signaling by NOTCH4 R-HSA-9013694
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH R-HSA-157118
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by VEGF R-HSA-194138
Signaling by NOTCH R-HSA-157118
Signaling by VEGF R-HSA-194138
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF ligand-receptor interactions R-HSA-194313
Signal Transduction R-HSA-162582
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signaling by NOTCH4 R-HSA-9013694
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signaling by VEGF R-HSA-194138
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694
Signaling by NOTCH R-HSA-157118
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signal Transduction R-HSA-162582
Signaling by NOTCH R-HSA-157118
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694
Signaling by VEGF R-HSA-194138
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signal Transduction R-HSA-162582
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by NOTCH R-HSA-157118
Signaling by VEGF R-HSA-194138
Signal Transduction R-HSA-162582
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signaling by NOTCH4 R-HSA-9013694
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by NOTCH R-HSA-157118
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF ligand-receptor interactions R-HSA-194313
Signal Transduction R-HSA-162582
Signaling by VEGF R-HSA-194138
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signal Transduction R-HSA-162582
Signaling by NOTCH R-HSA-157118
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by VEGF R-HSA-194138
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
Signaling by VEGF R-HSA-194138
VEGF ligand-receptor interactions R-HSA-194313
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signal Transduction R-HSA-162582
Signaling by NOTCH R-HSA-157118
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by NOTCH4 R-HSA-9013694
VEGF binds to VEGFR leading to receptor dimerization R-HSA-195399
NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695
Signaling by VEGF R-HSA-194138
Signaling by NOTCH R-HSA-157118
Signal Transduction R-HSA-162582
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
VEGF ligand-receptor interactions R-HSA-194313
Signaling by NOTCH4 R-HSA-9013694

Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Infectious disease R-HSA-5663205
Signal Transduction R-HSA-162582
RUNX2 regulates osteoblast differentiation R-HSA-8940973
PECAM1 interactions R-HSA-210990
Adaptive Immune System R-HSA-1280218
EPHB-mediated forward signaling R-HSA-3928662
Parasite infection R-HSA-9664407
Generic Transcription Pathway R-HSA-212436
EPH-ephrin mediated repulsion of cells R-HSA-3928665
FCGR3A-mediated phagocytosis R-HSA-9664422
Nervous system development R-HSA-9675108
Signaling by ERBB2 R-HSA-1227986
Regulation of signaling by CBL R-HSA-912631
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Axon guidance R-HSA-422475
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Cytokine Signaling in Immune system R-HSA-1280215
Gene expression (Transcription) R-HSA-74160
FCGR activation R-HSA-2029481
RUNX2 regulates bone development R-HSA-8941326
Regulation of KIT signaling R-HSA-1433559
Immune System R-HSA-168256
Signaling by Interleukins R-HSA-449147
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
EPH-Ephrin signaling R-HSA-2682334
Leishmania infection R-HSA-9658195
Leishmania parasite growth and survival R-HSA-9664433
Signaling by SCF-KIT R-HSA-1433557
Signaling by KIT in disease R-HSA-9669938
CTLA4 inhibitory signaling R-HSA-389513
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
EPHA-mediated growth cone collapse R-HSA-3928663
Costimulation by the CD28 family R-HSA-388841
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Leishmania phagocytosis R-HSA-9664417
Disease R-HSA-1643685
Cell surface interactions at the vascular wall R-HSA-202733
Transcriptional regulation by RUNX2 R-HSA-8878166
CD28 co-stimulation R-HSA-389356
Developmental Biology R-HSA-1266738
RNA Polymerase II Transcription R-HSA-73857
Hemostasis R-HSA-109582
Innate Immune System R-HSA-168249
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PECAM1 interactions R-HSA-210990
EPH-Ephrin signaling R-HSA-2682334
Axon guidance R-HSA-422475
Adaptive Immune System R-HSA-1280218
Parasite infection R-HSA-9664407
CD28 co-stimulation R-HSA-389356
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by KIT in disease R-HSA-9669938
Costimulation by the CD28 family R-HSA-388841
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Gene expression (Transcription) R-HSA-74160
Leishmania infection R-HSA-9658195
CTLA4 inhibitory signaling R-HSA-389513
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Infectious disease R-HSA-5663205
Transcriptional regulation by RUNX2 R-HSA-8878166
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Hemostasis R-HSA-109582
EPHB-mediated forward signaling R-HSA-3928662
Regulation of KIT signaling R-HSA-1433559
RUNX2 regulates bone development R-HSA-8941326
Innate Immune System R-HSA-168249
Signaling by ERBB2 R-HSA-1227986
Immune System R-HSA-168256
FCGR3A-mediated phagocytosis R-HSA-9664422
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signal Transduction R-HSA-162582
Leishmania phagocytosis R-HSA-9664417
Generic Transcription Pathway R-HSA-212436
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Disease R-HSA-1643685
Cell surface interactions at the vascular wall R-HSA-202733
Regulation of signaling by CBL R-HSA-912631
Signaling by Interleukins R-HSA-449147
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
FCGR activation R-HSA-2029481
Signaling by SCF-KIT R-HSA-1433557
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Developmental Biology R-HSA-1266738
RNA Polymerase II Transcription R-HSA-73857
Cytokine Signaling in Immune system R-HSA-1280215
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
CD28 co-stimulation R-HSA-389356
Adaptive Immune System R-HSA-1280218
Leishmania parasite growth and survival R-HSA-9664433
Costimulation by the CD28 family R-HSA-388841
Nervous system development R-HSA-9675108
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Disease R-HSA-1643685
Generic Transcription Pathway R-HSA-212436
Signal Transduction R-HSA-162582
RUNX2 regulates bone development R-HSA-8941326
FCGR activation R-HSA-2029481
Signaling by ERBB2 R-HSA-1227986
Signaling by Interleukins R-HSA-449147
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
EPHA-mediated growth cone collapse R-HSA-3928663
FCGR3A-mediated phagocytosis R-HSA-9664422
Immune System R-HSA-168256
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
RNA Polymerase II Transcription R-HSA-73857
Leishmania infection R-HSA-9658195
Innate Immune System R-HSA-168249
Signaling by SCF-KIT R-HSA-1433557
Gene expression (Transcription) R-HSA-74160
CTLA4 inhibitory signaling R-HSA-389513
PECAM1 interactions R-HSA-210990
Developmental Biology R-HSA-1266738
Transcriptional regulation by RUNX2 R-HSA-8878166
Axon guidance R-HSA-422475
Cell surface interactions at the vascular wall R-HSA-202733
Signaling by KIT in disease R-HSA-9669938
Infectious disease R-HSA-5663205
Cytokine Signaling in Immune system R-HSA-1280215
Leishmania phagocytosis R-HSA-9664417
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Regulation of KIT signaling R-HSA-1433559
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Hemostasis R-HSA-109582
EPH-Ephrin signaling R-HSA-2682334
FCGR3A-mediated phagocytosis R-HSA-9664422
Signal Transduction R-HSA-162582
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by KIT in disease R-HSA-9669938
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Nervous system development R-HSA-9675108
Regulation of signaling by CBL R-HSA-912631
RNA Polymerase II Transcription R-HSA-73857
Cell surface interactions at the vascular wall R-HSA-202733
Cytokine Signaling in Immune system R-HSA-1280215
Gene expression (Transcription) R-HSA-74160
CTLA4 inhibitory signaling R-HSA-389513
Disease R-HSA-1643685
CD28 co-stimulation R-HSA-389356
Axon guidance R-HSA-422475
EPHB-mediated forward signaling R-HSA-3928662
Innate Immune System R-HSA-168249
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Costimulation by the CD28 family R-HSA-388841
Adaptive Immune System R-HSA-1280218
Developmental Biology R-HSA-1266738
Signaling by ERBB2 R-HSA-1227986
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
EPH-Ephrin signaling R-HSA-2682334
Parasite infection R-HSA-9664407
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by SCF-KIT R-HSA-1433557
EPHA-mediated growth cone collapse R-HSA-3928663
Transcriptional regulation by RUNX2 R-HSA-8878166
Immune System R-HSA-168256
Hemostasis R-HSA-109582
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Signaling by Interleukins R-HSA-449147
Leishmania parasite growth and survival R-HSA-9664433
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Generic Transcription Pathway R-HSA-212436
PECAM1 interactions R-HSA-210990
RUNX2 regulates bone development R-HSA-8941326
Leishmania infection R-HSA-9658195
Regulation of KIT signaling R-HSA-1433559
Leishmania phagocytosis R-HSA-9664417
FCGR activation R-HSA-2029481
Infectious disease R-HSA-5663205
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
CD28 co-stimulation R-HSA-389356
Cell surface interactions at the vascular wall R-HSA-202733
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Axon guidance R-HSA-422475
EPHA-mediated growth cone collapse R-HSA-3928663
Transcriptional regulation by RUNX2 R-HSA-8878166
Signaling by KIT in disease R-HSA-9669938
Infectious disease R-HSA-5663205
Gene expression (Transcription) R-HSA-74160
Nervous system development R-HSA-9675108
RNA Polymerase II Transcription R-HSA-73857
Signaling by ERBB2 R-HSA-1227986
PECAM1 interactions R-HSA-210990
Hemostasis R-HSA-109582
CTLA4 inhibitory signaling R-HSA-389513
Generic Transcription Pathway R-HSA-212436
EPH-Ephrin signaling R-HSA-2682334
Leishmania infection R-HSA-9658195
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Immune System R-HSA-168256
FCGR activation R-HSA-2029481
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Interleukins R-HSA-449147
Signal Transduction R-HSA-162582
FCGR3A-mediated phagocytosis R-HSA-9664422
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by SCF-KIT R-HSA-1433557
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Innate Immune System R-HSA-168249
Costimulation by the CD28 family R-HSA-388841
Parasite infection R-HSA-9664407
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Regulation of KIT signaling R-HSA-1433559
Leishmania parasite growth and survival R-HSA-9664433
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FCGR3A-mediated IL10 synthesis R-HSA-9664323
EPHB-mediated forward signaling R-HSA-3928662
Developmental Biology R-HSA-1266738
RUNX2 regulates bone development R-HSA-8941326
Adaptive Immune System R-HSA-1280218
Disease R-HSA-1643685
Leishmania phagocytosis R-HSA-9664417
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Signaling by ERBB2 R-HSA-1227986
CD28 co-stimulation R-HSA-389356
Transcriptional regulation by RUNX2 R-HSA-8878166
Generic Transcription Pathway R-HSA-212436
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by Interleukins R-HSA-449147
EPHA-mediated growth cone collapse R-HSA-3928663
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signal Transduction R-HSA-162582
FCGR3A-mediated phagocytosis R-HSA-9664422
Disease R-HSA-1643685
Regulation of signaling by CBL R-HSA-912631
FCGR activation R-HSA-2029481
Leishmania phagocytosis R-HSA-9664417
Regulation of KIT signaling R-HSA-1433559
Infectious disease R-HSA-5663205
CTLA4 inhibitory signaling R-HSA-389513
Costimulation by the CD28 family R-HSA-388841
Axon guidance R-HSA-422475
EPH-Ephrin signaling R-HSA-2682334
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Innate Immune System R-HSA-168249
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Developmental Biology R-HSA-1266738
Signaling by SCF-KIT R-HSA-1433557
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
RNA Polymerase II Transcription R-HSA-73857
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Signaling by KIT in disease R-HSA-9669938
Adaptive Immune System R-HSA-1280218
Hemostasis R-HSA-109582
RUNX2 regulates bone development R-HSA-8941326
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
PECAM1 interactions R-HSA-210990
Leishmania infection R-HSA-9658195
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Gene expression (Transcription) R-HSA-74160
Cell surface interactions at the vascular wall R-HSA-202733
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
CD28 co-stimulation R-HSA-389356
PECAM1 interactions R-HSA-210990
Generic Transcription Pathway R-HSA-212436
FCGR3A-mediated IL10 synthesis R-HSA-9664323
RNA Polymerase II Transcription R-HSA-73857
Regulation of KIT signaling R-HSA-1433559
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Nervous system development R-HSA-9675108
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by SCF-KIT R-HSA-1433557
FCGR activation R-HSA-2029481
Leishmania infection R-HSA-9658195
Parasite infection R-HSA-9664407
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Axon guidance R-HSA-422475
Costimulation by the CD28 family R-HSA-388841
Hemostasis R-HSA-109582
Disease R-HSA-1643685
EPH-Ephrin signaling R-HSA-2682334
EPHB-mediated forward signaling R-HSA-3928662
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Infectious disease R-HSA-5663205
Leishmania phagocytosis R-HSA-9664417
FCGR3A-mediated phagocytosis R-HSA-9664422
Innate Immune System R-HSA-168249
Immune System R-HSA-168256
Gene expression (Transcription) R-HSA-74160
Regulation of signaling by CBL R-HSA-912631
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Developmental Biology R-HSA-1266738
Signaling by Interleukins R-HSA-449147
Signaling by KIT in disease R-HSA-9669938
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by ERBB2 R-HSA-1227986
Cytokine Signaling in Immune system R-HSA-1280215
CTLA4 inhibitory signaling R-HSA-389513
Transcriptional regulation by RUNX2 R-HSA-8878166
Signal Transduction R-HSA-162582
Cell surface interactions at the vascular wall R-HSA-202733
Adaptive Immune System R-HSA-1280218
RUNX2 regulates bone development R-HSA-8941326
Leishmania parasite growth and survival R-HSA-9664433
EPH-ephrin mediated repulsion of cells R-HSA-3928665
PECAM1 interactions R-HSA-210990
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Hemostasis R-HSA-109582
EPHB-mediated forward signaling R-HSA-3928662
Signal Transduction R-HSA-162582
Transcriptional regulation by RUNX2 R-HSA-8878166
RNA Polymerase II Transcription R-HSA-73857
Regulation of KIT signaling R-HSA-1433559
Signaling by SCF-KIT R-HSA-1433557
Innate Immune System R-HSA-168249
Axon guidance R-HSA-422475
Leishmania parasite growth and survival R-HSA-9664433
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates bone development R-HSA-8941326
CD28 co-stimulation R-HSA-389356
FCGR3A-mediated phagocytosis R-HSA-9664422
Disease R-HSA-1643685
Developmental Biology R-HSA-1266738
CTLA4 inhibitory signaling R-HSA-389513
EPH-Ephrin signaling R-HSA-2682334
Infectious disease R-HSA-5663205
FCGR3A-mediated IL10 synthesis R-HSA-9664323
EPH-ephrin mediated repulsion of cells R-HSA-3928665
Generic Transcription Pathway R-HSA-212436
Cell surface interactions at the vascular wall R-HSA-202733
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Cytokine Signaling in Immune system R-HSA-1280215
Immune System R-HSA-168256
FCGR activation R-HSA-2029481
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Signaling by ERBB2 R-HSA-1227986
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Adaptive Immune System R-HSA-1280218
Leishmania phagocytosis R-HSA-9664417
EPHA-mediated growth cone collapse R-HSA-3928663
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Costimulation by the CD28 family R-HSA-388841
Signaling by KIT in disease R-HSA-9669938
Signaling by Interleukins R-HSA-449147
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Nervous system development R-HSA-9675108
Leishmania infection R-HSA-9658195
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Gene expression (Transcription) R-HSA-74160
Parasite infection R-HSA-9664407
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
Signaling by Interleukins R-HSA-449147
EPHA-mediated growth cone collapse R-HSA-3928663
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Signaling by KIT in disease R-HSA-9669938
Costimulation by the CD28 family R-HSA-388841
Regulation of KIT signaling R-HSA-1433559
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Developmental Biology R-HSA-1266738
Leishmania phagocytosis R-HSA-9664417
Axon guidance R-HSA-422475
RNA Polymerase II Transcription R-HSA-73857
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
RUNX2 regulates bone development R-HSA-8941326
Hemostasis R-HSA-109582
Nervous system development R-HSA-9675108
PECAM1 interactions R-HSA-210990
CTLA4 inhibitory signaling R-HSA-389513
Signaling by ERBB2 R-HSA-1227986
RUNX2 regulates osteoblast differentiation R-HSA-8940973
Gene expression (Transcription) R-HSA-74160
Infectious disease R-HSA-5663205
EPH-Ephrin signaling R-HSA-2682334
FCGR activation R-HSA-2029481
Cell surface interactions at the vascular wall R-HSA-202733
Adaptive Immune System R-HSA-1280218
Signal Transduction R-HSA-162582
Transcriptional regulation by RUNX2 R-HSA-8878166
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Signaling by SCF-KIT R-HSA-1433557
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Cytokine Signaling in Immune system R-HSA-1280215
Leishmania infection R-HSA-9658195
Generic Transcription Pathway R-HSA-212436
CD28 co-stimulation R-HSA-389356
Parasite infection R-HSA-9664407
EPHB-mediated forward signaling R-HSA-3928662
EPH-ephrin mediated repulsion of cells R-HSA-3928665
FCGR3A-mediated phagocytosis R-HSA-9664422
Immune System R-HSA-168256
Leishmania parasite growth and survival R-HSA-9664433
Innate Immune System R-HSA-168249
Disease R-HSA-1643685
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Regulation of signaling by CBL R-HSA-912631
RUNX2 regulates osteoblast differentiation R-HSA-8940973
FCGR3A-mediated phagocytosis R-HSA-9664422
Signal Transduction R-HSA-162582
Interleukin-3, Interleukin-5 and GM-CSF signaling R-HSA-512988
Cell surface interactions at the vascular wall R-HSA-202733
Leishmania phagocytosis R-HSA-9664417
CTLA4 inhibitory signaling R-HSA-389513
Fcgamma receptor (FCGR) dependent phagocytosis R-HSA-2029480
FCGR3A-mediated IL10 synthesis R-HSA-9664323
Regulation of signaling by CBL R-HSA-912631
Nervous system development R-HSA-9675108
Leishmania parasite growth and survival R-HSA-9664433
Signaling by SCF-KIT R-HSA-1433557
Gene expression (Transcription) R-HSA-74160
PECAM1 interactions R-HSA-210990
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Immune System R-HSA-168256
Hemostasis R-HSA-109582
Signaling by KIT in disease R-HSA-9669938
EPHB-mediated forward signaling R-HSA-3928662
Adaptive Immune System R-HSA-1280218
RNA Polymerase II Transcription R-HSA-73857
EPHA-mediated growth cone collapse R-HSA-3928663
Leishmania infection R-HSA-9658195
Infectious disease R-HSA-5663205
Transcriptional regulation by RUNX2 R-HSA-8878166
Signaling by CSF1 (M-CSF) in myeloid cells R-HSA-9680350
Regulation of KIT signaling R-HSA-1433559
Axon guidance R-HSA-422475
Developmental Biology R-HSA-1266738
Signaling by ERBB2 R-HSA-1227986
RUNX2 regulates bone development R-HSA-8941326
FCGR activation R-HSA-2029481
Cytokine Signaling in Immune system R-HSA-1280215
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants R-HSA-9670439
Generic Transcription Pathway R-HSA-212436
Signaling by Interleukins R-HSA-449147
Disease R-HSA-1643685
Anti-inflammatory response favouring Leishmania parasite infection R-HSA-9662851
EPH-ephrin mediated repulsion of cells R-HSA-3928665
CD28 co-stimulation R-HSA-389356
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Parasite infection R-HSA-9664407
Costimulation by the CD28 family R-HSA-388841
EPH-Ephrin signaling R-HSA-2682334
Innate Immune System R-HSA-168249

MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by activated point mutants of FGFR1 R-HSA-1839122
MAPK family signaling cascades R-HSA-5683057
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Insulin receptor signalling cascade R-HSA-74751
Signaling by FGFR1 in disease R-HSA-5655302
Downstream signaling of activated FGFR1 R-HSA-5654687
RAF/MAP kinase cascade R-HSA-5673001
Gastrulation R-HSA-9758941
Signal Transduction R-HSA-162582
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
FGFR1 ligand binding and activation R-HSA-190242
Developmental Biology R-HSA-1266738
MAPK1/MAPK3 signaling R-HSA-5684996
PI3K Cascade R-HSA-109704
Signaling by FGFR in disease R-HSA-1226099
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Negative regulation of the PI3K/AKT network R-HSA-199418
IGF1R signaling cascade R-HSA-2428924
Intracellular signaling by second messengers R-HSA-9006925
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by FGFR1 R-HSA-5654736
L1CAM interactions R-HSA-373760
Signaling by FGFR R-HSA-190236
Formation of paraxial mesoderm R-HSA-9793380
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FRS-mediated FGFR1 signaling R-HSA-5654693
Axon guidance R-HSA-422475
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
PI-3K cascade:FGFR1 R-HSA-5654689
FGFR1b ligand binding and activation R-HSA-190370
Disease R-HSA-1643685
FGFR1c ligand binding and activation R-HSA-190373
Signal transduction by L1 R-HSA-445144
IRS-mediated signalling R-HSA-112399
Signaling by FGFR1 amplification mutants R-HSA-1839120
Signaling by Insulin receptor R-HSA-74752
IRS-related events triggered by IGF1R R-HSA-2428928
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Negative regulation of FGFR1 signaling R-HSA-5654726
PI3K/AKT Signaling in Cancer R-HSA-2219528
FGFR1 mutant receptor activation R-HSA-1839124
Nervous system development R-HSA-9675108
PIP3 activates AKT signaling R-HSA-1257604
SHC-mediated cascade:FGFR1 R-HSA-5654688
NCAM signaling for neurite out-growth R-HSA-375165
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
RAF/MAP kinase cascade R-HSA-5673001
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
IGF1R signaling cascade R-HSA-2428924
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
PI3K/AKT Signaling in Cancer R-HSA-2219528
FRS-mediated FGFR1 signaling R-HSA-5654693
Signaling by FGFR1 in disease R-HSA-5655302
NCAM signaling for neurite out-growth R-HSA-375165
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by FGFR1 R-HSA-5654736
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by FGFR R-HSA-190236
L1CAM interactions R-HSA-373760
Signal Transduction R-HSA-162582
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Negative regulation of FGFR1 signaling R-HSA-5654726
FGFR1 mutant receptor activation R-HSA-1839124
Axon guidance R-HSA-422475
MAPK1/MAPK3 signaling R-HSA-5684996
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
Downstream signaling of activated FGFR1 R-HSA-5654687
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
IRS-mediated signalling R-HSA-112399
Signaling by FGFR in disease R-HSA-1226099
FGFR1c and Klotho ligand binding and activation R-HSA-190374
IRS-related events triggered by IGF1R R-HSA-2428928
Signaling by Insulin receptor R-HSA-74752
Signal transduction by L1 R-HSA-445144
PI-3K cascade:FGFR1 R-HSA-5654689
PI3K Cascade R-HSA-109704
Intracellular signaling by second messengers R-HSA-9006925
Insulin receptor signalling cascade R-HSA-74751
SHC-mediated cascade:FGFR1 R-HSA-5654688
MAPK family signaling cascades R-HSA-5683057
FGFR1b ligand binding and activation R-HSA-190370
FGFR1 ligand binding and activation R-HSA-190242
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Developmental Biology R-HSA-1266738
Signaling by FGFR1 amplification mutants R-HSA-1839120
Gastrulation R-HSA-9758941
FGFR1c ligand binding and activation R-HSA-190373
Disease R-HSA-1643685
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by activated point mutants of FGFR1 R-HSA-1839122
Formation of paraxial mesoderm R-HSA-9793380
PIP3 activates AKT signaling R-HSA-1257604
Nervous system development R-HSA-9675108
Signaling by FGFR1 amplification mutants R-HSA-1839120
Formation of paraxial mesoderm R-HSA-9793380
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by Insulin receptor R-HSA-74752
Negative regulation of FGFR1 signaling R-HSA-5654726
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
RAF/MAP kinase cascade R-HSA-5673001
Gastrulation R-HSA-9758941
PI-3K cascade:FGFR1 R-HSA-5654689
Downstream signaling of activated FGFR1 R-HSA-5654687
SHC-mediated cascade:FGFR1 R-HSA-5654688
FGFR1 mutant receptor activation R-HSA-1839124
Signaling by activated point mutants of FGFR1 R-HSA-1839122
Signaling by FGFR1 in disease R-HSA-5655302
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
PI3K Cascade R-HSA-109704
PIP3 activates AKT signaling R-HSA-1257604
FGFR1c ligand binding and activation R-HSA-190373
Disease R-HSA-1643685
Signal Transduction R-HSA-162582
MAPK family signaling cascades R-HSA-5683057
L1CAM interactions R-HSA-373760
MAPK1/MAPK3 signaling R-HSA-5684996
NCAM signaling for neurite out-growth R-HSA-375165
Signaling by FGFR1 R-HSA-5654736
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Insulin receptor signalling cascade R-HSA-74751
FGFR1 ligand binding and activation R-HSA-190242
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by FGFR in disease R-HSA-1226099
IRS-related events triggered by IGF1R R-HSA-2428928
Signal transduction by L1 R-HSA-445144
Axon guidance R-HSA-422475
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Intracellular signaling by second messengers R-HSA-9006925
IRS-mediated signalling R-HSA-112399
Nervous system development R-HSA-9675108
IGF1R signaling cascade R-HSA-2428924
FRS-mediated FGFR1 signaling R-HSA-5654693
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Signaling by FGFR R-HSA-190236
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
FGFR1b ligand binding and activation R-HSA-190370
Developmental Biology R-HSA-1266738
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by FGFR R-HSA-190236
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
FRS-mediated FGFR1 signaling R-HSA-5654693
Downstream signaling of activated FGFR1 R-HSA-5654687
IRS-mediated signalling R-HSA-112399
PIP3 activates AKT signaling R-HSA-1257604
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Signaling by Insulin receptor R-HSA-74752
PI3K Cascade R-HSA-109704
Nervous system development R-HSA-9675108
PI-3K cascade:FGFR1 R-HSA-5654689
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Signal transduction by L1 R-HSA-445144
Gastrulation R-HSA-9758941
Signal Transduction R-HSA-162582
FGFR1b ligand binding and activation R-HSA-190370
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Negative regulation of FGFR1 signaling R-HSA-5654726
Disease R-HSA-1643685
RAF/MAP kinase cascade R-HSA-5673001
Intracellular signaling by second messengers R-HSA-9006925
Formation of paraxial mesoderm R-HSA-9793380
L1CAM interactions R-HSA-373760
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
IGF1R signaling cascade R-HSA-2428924
Signaling by activated point mutants of FGFR1 R-HSA-1839122
IRS-related events triggered by IGF1R R-HSA-2428928
Axon guidance R-HSA-422475
Signaling by FGFR1 amplification mutants R-HSA-1839120
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by FGFR1 in disease R-HSA-5655302
Signaling by FGFR1 R-HSA-5654736
Insulin receptor signalling cascade R-HSA-74751
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Signaling by FGFR in disease R-HSA-1226099
FGFR1c ligand binding and activation R-HSA-190373
NCAM signaling for neurite out-growth R-HSA-375165
MAPK1/MAPK3 signaling R-HSA-5684996
FGFR1 ligand binding and activation R-HSA-190242
Negative regulation of the PI3K/AKT network R-HSA-199418
Developmental Biology R-HSA-1266738
MAPK family signaling cascades R-HSA-5683057
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
SHC-mediated cascade:FGFR1 R-HSA-5654688
FGFR1 mutant receptor activation R-HSA-1839124
Negative regulation of the PI3K/AKT network R-HSA-199418
Nervous system development R-HSA-9675108
FGFR1b ligand binding and activation R-HSA-190370
L1CAM interactions R-HSA-373760
Formation of paraxial mesoderm R-HSA-9793380
Signaling by activated point mutants of FGFR1 R-HSA-1839122
Signaling by FGFR1 R-HSA-5654736
PIP3 activates AKT signaling R-HSA-1257604
RAF/MAP kinase cascade R-HSA-5673001
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
IGF1R signaling cascade R-HSA-2428924
Intracellular signaling by second messengers R-HSA-9006925
SHC-mediated cascade:FGFR1 R-HSA-5654688
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
FGFR1c ligand binding and activation R-HSA-190373
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Signal transduction by L1 R-HSA-445144
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
IRS-mediated signalling R-HSA-112399
Signaling by FGFR1 in disease R-HSA-5655302
Negative regulation of FGFR1 signaling R-HSA-5654726
Signal Transduction R-HSA-162582
Gastrulation R-HSA-9758941
PI3K Cascade R-HSA-109704
Signaling by FGFR1 amplification mutants R-HSA-1839120
Developmental Biology R-HSA-1266738
Signaling by FGFR R-HSA-190236
IRS-related events triggered by IGF1R R-HSA-2428928
FRS-mediated FGFR1 signaling R-HSA-5654693
Disease R-HSA-1643685
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Insulin receptor R-HSA-74752
FGFR1 ligand binding and activation R-HSA-190242
MAPK family signaling cascades R-HSA-5683057
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Axon guidance R-HSA-422475
PI3K/AKT Signaling in Cancer R-HSA-2219528
Insulin receptor signalling cascade R-HSA-74751
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
PI-3K cascade:FGFR1 R-HSA-5654689
NCAM signaling for neurite out-growth R-HSA-375165
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Signaling by FGFR in disease R-HSA-1226099
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Downstream signaling of activated FGFR1 R-HSA-5654687
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
FGFR1 mutant receptor activation R-HSA-1839124
NCAM signaling for neurite out-growth R-HSA-375165
PIP3 activates AKT signaling R-HSA-1257604
Formation of paraxial mesoderm R-HSA-9793380
MAPK1/MAPK3 signaling R-HSA-5684996
Axon guidance R-HSA-422475
FGFR1c ligand binding and activation R-HSA-190373
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by FGFR R-HSA-190236
Intracellular signaling by second messengers R-HSA-9006925
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Disease R-HSA-1643685
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by FGFR in disease R-HSA-1226099
Signal Transduction R-HSA-162582
MAPK family signaling cascades R-HSA-5683057
Insulin receptor signalling cascade R-HSA-74751
FGFR1 ligand binding and activation R-HSA-190242
Signal transduction by L1 R-HSA-445144
PI3K Cascade R-HSA-109704
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
RAF/MAP kinase cascade R-HSA-5673001
FGFR1b ligand binding and activation R-HSA-190370
Signaling by Insulin receptor R-HSA-74752
Signaling by FGFR1 amplification mutants R-HSA-1839120
Signaling by activated point mutants of FGFR1 R-HSA-1839122
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Gastrulation R-HSA-9758941
Nervous system development R-HSA-9675108
SHC-mediated cascade:FGFR1 R-HSA-5654688
Developmental Biology R-HSA-1266738
Signaling by FGFR1 R-HSA-5654736
Negative regulation of FGFR1 signaling R-HSA-5654726
FRS-mediated FGFR1 signaling R-HSA-5654693
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
L1CAM interactions R-HSA-373760
Downstream signaling of activated FGFR1 R-HSA-5654687
IRS-related events triggered by IGF1R R-HSA-2428928
IGF1R signaling cascade R-HSA-2428924
Signaling by FGFR1 in disease R-HSA-5655302
IRS-mediated signalling R-HSA-112399
PI-3K cascade:FGFR1 R-HSA-5654689
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
FGFR1 mutant receptor activation R-HSA-1839124
Formation of paraxial mesoderm R-HSA-9793380
Signaling by FGFR1 R-HSA-5654736
MAPK family signaling cascades R-HSA-5683057
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
NCAM signaling for neurite out-growth R-HSA-375165
Signaling by FGFR1 in disease R-HSA-5655302
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
IGF1R signaling cascade R-HSA-2428924
Disease R-HSA-1643685
Signaling by FGFR in disease R-HSA-1226099
Insulin receptor signalling cascade R-HSA-74751
FGFR1c and Klotho ligand binding and activation R-HSA-190374
RAF/MAP kinase cascade R-HSA-5673001
Signaling by Insulin receptor R-HSA-74752
Signaling by activated point mutants of FGFR1 R-HSA-1839122
PIP3 activates AKT signaling R-HSA-1257604
FRS-mediated FGFR1 signaling R-HSA-5654693
Intracellular signaling by second messengers R-HSA-9006925
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
SHC-mediated cascade:FGFR1 R-HSA-5654688
Axon guidance R-HSA-422475
IRS-mediated signalling R-HSA-112399
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
FGFR1c ligand binding and activation R-HSA-190373
Nervous system development R-HSA-9675108
Signal Transduction R-HSA-162582
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
L1CAM interactions R-HSA-373760
Signal transduction by L1 R-HSA-445144
PI3K Cascade R-HSA-109704
PI3K/AKT Signaling in Cancer R-HSA-2219528
Downstream signaling of activated FGFR1 R-HSA-5654687
PI-3K cascade:FGFR1 R-HSA-5654689
FGFR1 ligand binding and activation R-HSA-190242
Signaling by FGFR1 amplification mutants R-HSA-1839120
Negative regulation of FGFR1 signaling R-HSA-5654726
Developmental Biology R-HSA-1266738
FGFR1b ligand binding and activation R-HSA-190370
FGFR1 mutant receptor activation R-HSA-1839124
Signaling by FGFR R-HSA-190236
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Negative regulation of the PI3K/AKT network R-HSA-199418
Gastrulation R-HSA-9758941
IRS-related events triggered by IGF1R R-HSA-2428928
FGFR1c ligand binding and activation R-HSA-190373
Disease R-HSA-1643685
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
RAF/MAP kinase cascade R-HSA-5673001
IRS-related events triggered by IGF1R R-HSA-2428928
IRS-mediated signalling R-HSA-112399
SHC-mediated cascade:FGFR1 R-HSA-5654688
Nervous system development R-HSA-9675108
PIP3 activates AKT signaling R-HSA-1257604
MAPK family signaling cascades R-HSA-5683057
Signaling by FGFR in disease R-HSA-1226099
Negative regulation of FGFR1 signaling R-HSA-5654726
Developmental Biology R-HSA-1266738
Signaling by Insulin receptor R-HSA-74752
Signaling by FGFR1 in disease R-HSA-5655302
PI3K/AKT Signaling in Cancer R-HSA-2219528
FGFR1b ligand binding and activation R-HSA-190370
IGF1R signaling cascade R-HSA-2428924
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
FGFR1 ligand binding and activation R-HSA-190242
Insulin receptor signalling cascade R-HSA-74751
Negative regulation of the PI3K/AKT network R-HSA-199418
NCAM signaling for neurite out-growth R-HSA-375165
PI-3K cascade:FGFR1 R-HSA-5654689
Axon guidance R-HSA-422475
Signal Transduction R-HSA-162582
Gastrulation R-HSA-9758941
Downstream signaling of activated FGFR1 R-HSA-5654687
Signaling by activated point mutants of FGFR1 R-HSA-1839122
Signal transduction by L1 R-HSA-445144
L1CAM interactions R-HSA-373760
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
FRS-mediated FGFR1 signaling R-HSA-5654693
FGFR1 mutant receptor activation R-HSA-1839124
Formation of paraxial mesoderm R-HSA-9793380
Signaling by FGFR R-HSA-190236
FGFR1c and Klotho ligand binding and activation R-HSA-190374
PI3K Cascade R-HSA-109704
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by FGFR1 amplification mutants R-HSA-1839120
Intracellular signaling by second messengers R-HSA-9006925
Signaling by FGFR1 R-HSA-5654736
MAPK1/MAPK3 signaling R-HSA-5684996
Downstream signaling of activated FGFR1 R-HSA-5654687
Signal Transduction R-HSA-162582
Disease R-HSA-1643685
FGFR1c ligand binding and activation R-HSA-190373
IGF1R signaling cascade R-HSA-2428924
Nervous system development R-HSA-9675108
FGFR1 ligand binding and activation R-HSA-190242
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by FGFR R-HSA-190236
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Insulin receptor signalling cascade R-HSA-74751
L1CAM interactions R-HSA-373760
Intracellular signaling by second messengers R-HSA-9006925
Signaling by activated point mutants of FGFR1 R-HSA-1839122
PIP3 activates AKT signaling R-HSA-1257604
Signaling by FGFR1 in disease R-HSA-5655302
Signal transduction by L1 R-HSA-445144
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
Signaling by FGFR1 R-HSA-5654736
IRS-mediated signalling R-HSA-112399
Signaling by FGFR in disease R-HSA-1226099
NCAM signaling for neurite out-growth R-HSA-375165
IRS-related events triggered by IGF1R R-HSA-2428928
PI-3K cascade:FGFR1 R-HSA-5654689
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Negative regulation of the PI3K/AKT network R-HSA-199418
PI3K/AKT Signaling in Cancer R-HSA-2219528
Developmental Biology R-HSA-1266738
FGFR1 mutant receptor activation R-HSA-1839124
Signaling by FGFR1 amplification mutants R-HSA-1839120
Axon guidance R-HSA-422475
FGFR1c and Klotho ligand binding and activation R-HSA-190374
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by Insulin receptor R-HSA-74752
Formation of paraxial mesoderm R-HSA-9793380
SHC-mediated cascade:FGFR1 R-HSA-5654688
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Negative regulation of FGFR1 signaling R-HSA-5654726
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI3K Cascade R-HSA-109704
FRS-mediated FGFR1 signaling R-HSA-5654693
MAPK family signaling cascades R-HSA-5683057
Gastrulation R-HSA-9758941
RAF/MAP kinase cascade R-HSA-5673001
FGFR1b ligand binding and activation R-HSA-190370
Developmental Biology R-HSA-1266738
Intracellular signaling by second messengers R-HSA-9006925
Signaling by FGFR R-HSA-190236
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
FGFR1 mutant receptor activation R-HSA-1839124
Signal Transduction R-HSA-162582
IRS-related events triggered by IGF1R R-HSA-2428928
Formation of paraxial mesoderm R-HSA-9793380
PI3K Cascade R-HSA-109704
Disease R-HSA-1643685
L1CAM interactions R-HSA-373760
Signal transduction by L1 R-HSA-445144
PI-3K cascade:FGFR1 R-HSA-5654689
Signaling by FGFR1 in disease R-HSA-5655302
MAPK family signaling cascades R-HSA-5683057
IRS-mediated signalling R-HSA-112399
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by activated point mutants of FGFR1 R-HSA-1839122
Epithelial-Mesenchymal Transition (EMT) during gastrulation R-HSA-9758919
Signaling by FGFR1 R-HSA-5654736
Signaling by FGFR1 amplification mutants R-HSA-1839120
FGFR1c and Klotho ligand binding and activation R-HSA-190374
Signaling by Insulin receptor R-HSA-74752
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by plasma membrane FGFR1 fusions R-HSA-8853336
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
RAF/MAP kinase cascade R-HSA-5673001
SHC-mediated cascade:FGFR1 R-HSA-5654688
Axon guidance R-HSA-422475
IGF1R signaling cascade R-HSA-2428924
MAPK1/MAPK3 signaling R-HSA-5684996
Nervous system development R-HSA-9675108
Downstream signaling of activated FGFR1 R-HSA-5654687
PIP3 activates AKT signaling R-HSA-1257604
Negative regulation of FGFR1 signaling R-HSA-5654726
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192
Gastrulation R-HSA-9758941
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
NCAM signaling for neurite out-growth R-HSA-375165
Phospholipase C-mediated cascade: FGFR1 R-HSA-5654219
Insulin receptor signalling cascade R-HSA-74751
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
FGFR1b ligand binding and activation R-HSA-190370
FGFR1 ligand binding and activation R-HSA-190242
FGFR1c ligand binding and activation R-HSA-190373
Signaling by FGFR in disease R-HSA-1226099
FRS-mediated FGFR1 signaling R-HSA-5654693

RAF/MAP kinase cascade R-HSA-5673001
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by PDGF R-HSA-186797
PI3K/AKT Signaling in Cancer R-HSA-2219528
Sunitinib-resistant PDGFR mutants R-HSA-9674401
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Imatinib-resistant PDGFR mutants R-HSA-9674396
Drug resistance of PDGFR mutants R-HSA-9674415
MAPK family signaling cascades R-HSA-5683057
PDGFR mutants bind TKIs R-HSA-9674428
MAPK1/MAPK3 signaling R-HSA-5684996
Disease R-HSA-1643685
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Downstream signal transduction R-HSA-186763
Signaling by PDGFR in disease R-HSA-9671555
Signal Transduction R-HSA-162582
PIP3 activates AKT signaling R-HSA-1257604
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Intracellular signaling by second messengers R-HSA-9006925
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Downstream signal transduction R-HSA-186763
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Sunitinib-resistant PDGFR mutants R-HSA-9674401
RAF/MAP kinase cascade R-HSA-5673001
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Regorafenib-resistant PDGFR mutants R-HSA-9674403
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Intracellular signaling by second messengers R-HSA-9006925
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Negative regulation of the PI3K/AKT network R-HSA-199418
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
PI3K/AKT Signaling in Cancer R-HSA-2219528
Disease R-HSA-1643685
PDGFR mutants bind TKIs R-HSA-9674428
Imatinib-resistant PDGFR mutants R-HSA-9674396
PIP3 activates AKT signaling R-HSA-1257604
Signaling by PDGFR in disease R-HSA-9671555
Drug resistance of PDGFR mutants R-HSA-9674415
Signaling by PDGF R-HSA-186797
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
MAPK family signaling cascades R-HSA-5683057
Signal Transduction R-HSA-162582
Intracellular signaling by second messengers R-HSA-9006925
RAF/MAP kinase cascade R-HSA-5673001
PI3K/AKT Signaling in Cancer R-HSA-2219528
PIP3 activates AKT signaling R-HSA-1257604
Signal Transduction R-HSA-162582
Signaling by PDGF R-HSA-186797
Signaling by PDGFR in disease R-HSA-9671555
Downstream signal transduction R-HSA-186763
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
MAPK1/MAPK3 signaling R-HSA-5684996
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
MAPK family signaling cascades R-HSA-5683057
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Negative regulation of the PI3K/AKT network R-HSA-199418
Imatinib-resistant PDGFR mutants R-HSA-9674396
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PDGFR mutants bind TKIs R-HSA-9674428
Disease R-HSA-1643685
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Drug resistance of PDGFR mutants R-HSA-9674415
Imatinib-resistant PDGFR mutants R-HSA-9674396
PI3K/AKT Signaling in Cancer R-HSA-2219528
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Drug resistance of PDGFR mutants R-HSA-9674415
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
MAPK family signaling cascades R-HSA-5683057
RAF/MAP kinase cascade R-HSA-5673001
Negative regulation of the PI3K/AKT network R-HSA-199418
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signal Transduction R-HSA-162582
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Signaling by PDGFR in disease R-HSA-9671555
PDGFR mutants bind TKIs R-HSA-9674428
Disease R-HSA-1643685
Signaling by PDGF R-HSA-186797
Sorafenib-resistant PDGFR mutants R-HSA-9674404
MAPK1/MAPK3 signaling R-HSA-5684996
Intracellular signaling by second messengers R-HSA-9006925
Downstream signal transduction R-HSA-186763
PIP3 activates AKT signaling R-HSA-1257604
MAPK1/MAPK3 signaling R-HSA-5684996
Downstream signal transduction R-HSA-186763
Signaling by PDGF R-HSA-186797
Signaling by PDGFR in disease R-HSA-9671555
RAF/MAP kinase cascade R-HSA-5673001
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Disease R-HSA-1643685
PDGFR mutants bind TKIs R-HSA-9674428
Negative regulation of the PI3K/AKT network R-HSA-199418
Signal Transduction R-HSA-162582
Drug resistance of PDGFR mutants R-HSA-9674415
Imatinib-resistant PDGFR mutants R-HSA-9674396
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Intracellular signaling by second messengers R-HSA-9006925
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
PI3K/AKT Signaling in Cancer R-HSA-2219528
Regorafenib-resistant PDGFR mutants R-HSA-9674403
MAPK family signaling cascades R-HSA-5683057
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
PIP3 activates AKT signaling R-HSA-1257604
Signaling by PDGFR in disease R-HSA-9671555
Downstream signal transduction R-HSA-186763
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
PI3K/AKT Signaling in Cancer R-HSA-2219528
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Intracellular signaling by second messengers R-HSA-9006925
Disease R-HSA-1643685
Imatinib-resistant PDGFR mutants R-HSA-9674396
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
RAF/MAP kinase cascade R-HSA-5673001
Signal Transduction R-HSA-162582
PDGFR mutants bind TKIs R-HSA-9674428
MAPK family signaling cascades R-HSA-5683057
Negative regulation of the PI3K/AKT network R-HSA-199418
Signaling by PDGF R-HSA-186797
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
PIP3 activates AKT signaling R-HSA-1257604
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
MAPK1/MAPK3 signaling R-HSA-5684996
Drug resistance of PDGFR mutants R-HSA-9674415
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Intracellular signaling by second messengers R-HSA-9006925
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by PDGFR in disease R-HSA-9671555
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
PDGFR mutants bind TKIs R-HSA-9674428
MAPK1/MAPK3 signaling R-HSA-5684996
Downstream signal transduction R-HSA-186763
Drug resistance of PDGFR mutants R-HSA-9674415
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Imatinib-resistant PDGFR mutants R-HSA-9674396
Signal Transduction R-HSA-162582
Negative regulation of the PI3K/AKT network R-HSA-199418
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by PDGF R-HSA-186797
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Disease R-HSA-1643685
RAF/MAP kinase cascade R-HSA-5673001
PIP3 activates AKT signaling R-HSA-1257604
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
MAPK family signaling cascades R-HSA-5683057
MAPK1/MAPK3 signaling R-HSA-5684996
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Signaling by PDGF R-HSA-186797
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Disease R-HSA-1643685
Drug resistance of PDGFR mutants R-HSA-9674415
PDGFR mutants bind TKIs R-HSA-9674428
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Signal Transduction R-HSA-162582
PI3K/AKT Signaling in Cancer R-HSA-2219528
Intracellular signaling by second messengers R-HSA-9006925
Negative regulation of the PI3K/AKT network R-HSA-199418
Sunitinib-resistant PDGFR mutants R-HSA-9674401
Downstream signal transduction R-HSA-186763
PIP3 activates AKT signaling R-HSA-1257604
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Imatinib-resistant PDGFR mutants R-HSA-9674396
MAPK family signaling cascades R-HSA-5683057
Signaling by PDGFR in disease R-HSA-9671555
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
RAF/MAP kinase cascade R-HSA-5673001
RAF/MAP kinase cascade R-HSA-5673001
Negative regulation of the PI3K/AKT network R-HSA-199418
MAPK1/MAPK3 signaling R-HSA-5684996
Downstream signal transduction R-HSA-186763
Sunitinib-resistant PDGFR mutants R-HSA-9674401
PI3K/AKT Signaling in Cancer R-HSA-2219528
MAPK family signaling cascades R-HSA-5683057
Drug resistance of PDGFR mutants R-HSA-9674415
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Imatinib-resistant PDGFR mutants R-HSA-9674396
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Disease R-HSA-1643685
PDGFR mutants bind TKIs R-HSA-9674428
Signaling by PDGFR in disease R-HSA-9671555
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Regorafenib-resistant PDGFR mutants R-HSA-9674403
PIP3 activates AKT signaling R-HSA-1257604
Signal Transduction R-HSA-162582
Intracellular signaling by second messengers R-HSA-9006925
Signaling by PDGF R-HSA-186797
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
RAF/MAP kinase cascade R-HSA-5673001
Drug resistance of PDGFR mutants R-HSA-9674415
PDGFR mutants bind TKIs R-HSA-9674428
MAPK1/MAPK3 signaling R-HSA-5684996
Diseases of signal transduction by growth factor receptors and second messengers R-HSA-5663202
Disease R-HSA-1643685
Regorafenib-resistant PDGFR mutants R-HSA-9674403
Downstream signal transduction R-HSA-186763
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling R-HSA-6811558
Constitutive Signaling by Aberrant PI3K in Cancer R-HSA-2219530
Sunitinib-resistant PDGFR mutants R-HSA-9674401
PIP3 activates AKT signaling R-HSA-1257604
Intracellular signaling by second messengers R-HSA-9006925
Sorafenib-resistant PDGFR mutants R-HSA-9674404
Signaling by Receptor Tyrosine Kinases R-HSA-9006934
Imatinib-resistant PDGFR mutants R-HSA-9674396
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants R-HSA-9673767
Signal Transduction R-HSA-162582
Signaling by PDGFRA extracellular domain mutants R-HSA-9673770
Signaling by PDGF R-HSA-186797
MAPK family signaling cascades R-HSA-5683057
PI3K/AKT Signaling in Cancer R-HSA-2219528
Signaling by PDGFR in disease R-HSA-9671555
Negative regulation of the PI3K/AKT network R-HSA-199418